Butler John P. (CIK 0001591467)

Latest company ownership

Shares held
375,865
Last filed at
Feb 18, 2022
Confidence Score
50.5
2025Q4
Confidence Score History
2014Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 3, 2025 Mar 4, 2025 Akebia Therapeutics, Inc. CEO Sell 45.0 -46,409 -1.59% ✓ $84.9K
Jan 31, 2025 Feb 4, 2025 Akebia Therapeutics, Inc. CEO Sell 97.5 +556,750 23.52% ✓ $302.9K
Feb 29, 2024 Mar 1, 2024 Akebia Therapeutics, Inc. CEO Sell 42.5 -46,570 -1.93% ✗ $73.6K
Feb 27, 2024 Feb 29, 2024 Akebia Therapeutics, Inc. CEO Sell 42.5 -37,733 -1.54% ✗ $57.4K
Jan 31, 2024 Feb 2, 2024 Akebia Therapeutics, Inc. CEO Sell 95.0 +557,011 29.44% ✗ $78.1K
Mar 1, 2023 Mar 3, 2023 Akebia Therapeutics, Inc. CEO Sell 42.5 -91,868 -4.64% ✗ $80.6K
Feb 27, 2023 Mar 1, 2023 Akebia Therapeutics, Inc. CEO Sell 46.3 -38,632 -1.91% ✗ $31.4K
Feb 28, 2022 Mar 2, 2022 Akebia Therapeutics, Inc. CEO Sell 95.0 +214,099 14.19% ✗ $171.1K
Apr 1, 2021 Apr 1, 2021 Akebia Therapeutics, Inc. CEO Sell 51.3 -4,109 -0.27% ✗ $14K
Feb 26, 2021 Mar 2, 2021 Akebia Therapeutics, Inc. CEO Sell 95.0 +187,410 14.29% ✗ $169.8K
Nov 20, 2019 Nov 21, 2019 Akebia Therapeutics, Inc. CEO Buy 87.5 +50,000 4.90% ✗ $172K
Dec 12, 2018 Dec 13, 2018 Akebia Therapeutics, Inc. CEO Sell 17.5 -135,697 -21.64% ✗ $1.2M
Dec 29, 2014 Dec 29, 2014 Akebia Therapeutics, Inc. CEO Buy 78.8 +1,000 2.11% ✓ $11.6K
Dec 22, 2014 Dec 22, 2014 Akebia Therapeutics, Inc. CEO Buy 78.8 +1,000 2.16% ✓ $11.9K
Dec 15, 2014 Dec 18, 2014 Akebia Therapeutics, Inc. CEO Buy 78.8 +1,000 2.21% ✓ $11.3K
Nov 11, 2014 Nov 13, 2014 Akebia Therapeutics, Inc. CEO Buy 78.8 +1,000 2.25% ✗ $10.3K
Mar 25, 2014 Mar 27, 2014 Akebia Therapeutics, Inc. CEO Buy 95.0 +13,850 100.00% ✗ $235.5K